← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: USPHARMA · Approved 2026-02-09

Drug application

FDA Application #
ANDA207059
Application type
Abbreviated New Drug Application (Generic)
Brand name
LIDOCAINE
Generic name
Lidocaine
Active ingredients
LIDOCAINE
Dosage form
PATCH
Route
TOPICAL
Marketing status
Prescription
Sponsor
USPHARMA
First approval
2026-02-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown